Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,610 | 4 | 96.2% |
| Food and Beverage | $142.02 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,500 | 1 | $0 (2023) |
| Eagle Pharmaceuticals, Inc. | $500.00 | 1 | $0 (2019) |
| Theravance Biopharma, Inc. | $310.00 | 1 | $0 (2018) |
| Galt Pharmaceuticals, LLC | $300.00 | 1 | $0 (2023) |
| Coherus Biosciences Inc. | $142.02 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.02 | 1 | Coherus Biosciences Inc. ($142.02) |
| 2023 | $2,800 | 2 | GlaxoSmithKline, LLC. ($2,500) |
| 2019 | $500.00 | 1 | Eagle Pharmaceuticals, Inc. ($500.00) |
| 2018 | $310.00 | 1 | Theravance Biopharma, Inc. ($310.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | Coherus Biosciences Inc. | — | Food and Beverage | In-kind items and services | $142.02 | General |
| 04/04/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 01/31/2023 | Galt Pharmaceuticals, LLC | Oravig (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: AntiFungal | ||||||
| 01/30/2019 | Eagle Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 03/13/2018 | Theravance Biopharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $310.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 100 | 127 | $36,166 | $10,269 |
| 2022 | 3 | 67 | 88 | $23,550 | $6,964 |
| 2021 | 4 | 72 | 85 | $30,044 | $9,898 |
| 2020 | 2 | 37 | 55 | $14,053 | $4,374 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 39 | 59 | $15,104 | $4,601 | 30.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 18 | $6,840 | $2,112 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $6,765 | $1,563 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 23 | $3,841 | $1,163 | 30.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 12 | $3,616 | $830.76 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 39 | 58 | $14,848 | $4,618 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 13 | 13 | $5,863 | $1,379 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 17 | $2,839 | $966.94 | 34.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 20 | 20 | $9,612 | $3,111 | 32.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 22 | $8,155 | $2,787 | 34.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 23 | 32 | $7,868 | $2,709 | 34.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $4,409 | $1,291 | 29.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 23 | 41 | $9,119 | $2,809 | 30.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 14 | 14 | $4,934 | $1,566 | 31.7% |
About Joel Epstein
Joel Epstein is a Dentist healthcare provider based in Duarte, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083729131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joel Epstein has received a total of $3,752 in payments from pharmaceutical and medical device companies, with $142.02 received in 2024. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($3,610).
As a Medicare-enrolled provider, Epstein has provided services to 276 Medicare beneficiaries, totaling 355 services with total Medicare billing of $31,506. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Dentist
- Location Duarte, CA
- Active Since 08/20/2006
- Last Updated 03/07/2023
- Taxonomy Code 122300000X
- Entity Type Individual
- NPI Number 1083729131
Products in Payments
- Oravig (Drug) $300.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.